GlobeNewswire
-
Mammogen Launches Leadership Council to Unite Industry Experts and Survivors, Names Former Quest Diagnostics CMO Dr. Yuri Fesko as Founding Member
17/11/2026 -
Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
17/11/2026 -
ProMIS Neurosciences Licenses Next-Generation TXP1 Brain-Selective Shuttling Technology from Ossianix to Expand PMN310 Franchise and Pipeline
17/11/2026 -
Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development
17/11/2026 -
CancerVax Successfully Kills Cancer Cells in Landmark Test
17/11/2026 -
Biocomposites welcomes new clinical pathway for local infection management in severe pressure ulcers
17/11/2026 -
Rapid Nutrition Announces SystemLS AI Mobile App to Accelerate International Growth and Create Recurring Subscription Revenue Opportunity
17/11/2026 -
Commit Biologics announces final close of $60 million seed financing to advance complement-powered immune engagers toward the clinic
17/11/2026 -
AriBio’s Oral AR1001 Meets Primary Efficacy Objective in Prespecified Monotherapy Population in Phase 3 POLARIS-AD Trial
17/11/2026 -
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
17/11/2026 -
InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026
16/11/2026 -
Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Glass House Brands Reports Third Quarter 2026 Financial Results
16/11/2026 -
ORIC® Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Operational and Rinzimetostat Program Updates
16/11/2026 -
20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates
16/11/2026 -
LeonaBio Reports Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Nanox to Report Third Quarter 2026 Financial Results on November 25, 2026
16/11/2026 -
Insight Molecular Diagnostics Announces Proposed Public Offering
16/11/2026
Pages